0001062993-23-011389.txt : 20230517
0001062993-23-011389.hdr.sgml : 20230517
20230517162637
ACCESSION NUMBER: 0001062993-23-011389
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230515
FILED AS OF DATE: 20230517
DATE AS OF CHANGE: 20230517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Murphy Polly A.
CENTRAL INDEX KEY: 0001829248
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38207
FILM NUMBER: 23932111
MAIL ADDRESS:
STREET 1: C/O ATEA PHARMACEUTICALS, INC.
STREET 2: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celcuity Inc.
CENTRAL INDEX KEY: 0001603454
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 16305 36TH AVENUE N
STREET 2: SUITE 100
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55446
BUSINESS PHONE: 763-392-0767
MAIL ADDRESS:
STREET 1: 16305 36TH AVENUE N
STREET 2: SUITE 100
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55446
FORMER COMPANY:
FORMER CONFORMED NAME: Celcuity LLC
DATE OF NAME CHANGE: 20140324
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0407
4
2023-05-15
0001603454
Celcuity Inc.
CELC
0001829248
Murphy Polly A.
16305 36TH AVENUE N.
SUITE 100
MINNEAPOLIS
MN
55446
1
0
0
0
0
Common Stock
5000
D
Stock Option (right to buy)
8.31
2032-09-12
Common Stock
10000
10000
D
Stock Option (right to buy)
8.31
2032-09-12
Common Stock
16300
16300
D
Stock Option (right to buy)
9.58
2023-05-15
4
A
0
11645
0
A
2033-05-15
Common Stock
11645
11645
D
2,500 shares vest on each of 9/12/23, 9/12/24, 9/12/25 and 9/12/26.
Fully vested.
This Option will vest and become exercisable on April 30, 2024, or if earlier, the date of the Company's 2024 Annual Meeting of Stockholders.
/s/ Eric O. Madson as Attorney-in-Fact for Polly A. Murphy pursuant to Power of Attorney previously filed.
2023-05-17